Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002355625 | SCV002620516 | uncertain significance | Cardiovascular phenotype | 2019-03-28 | criteria provided, single submitter | clinical testing | The p.Y12904C variant (also known as c.38711A>G), located in coding exon 141 of the TTN gene, results from an A to G substitution at nucleotide position 38711. The tyrosine at codon 12904 is replaced by cysteine, an amino acid with highly dissimilar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |